Answer to Question 1
Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) stimulate insulin secretion. GLP-1 also suppresses glucagon and slows gastric emptying, which delays digestion and reduces postprandial glycemia. GLP-1 also acts on the hypothalamus to induce satiety. Bariatric surgery increases the levels of these hormones and are hypothesized to dramatically improve glycemic control post-operatively.
Weight loss will improve insulin sensitivity and contribute to improved glycemic control.
Bariatric surgery restricts food intake to a small portion of food at each sitting, which increases satiety and helps prevent hyperglycemia.
Other conditions that may be affected by weight loss include cardiovascular disease. If hyperglycemia can be controlled, it may reduce the damage to the blood vessels, which aids in reducing risk of cardiovascular disease.
Sleep apnea will be improved with weight reduction, as there is less mass around the respiratory muscles.
Hyperlipidemia can be improved. As the patient eats more consistently with a decreased capacity, lipid profiles may begin to normalize as the patient loses weight.
Blood pressure can be lowered with weight reduction, aiding in resolving hypertension.
May reduce risk of cancer as obesity is linked with some forms of cancers
May improve psychological health as obesity is associated with feelings of guilt, depression, anxiety, and low self-worth
Answer to Question 2
SBW is 60 kg and her aBWef is 70 kg
70 x 35 = 2450 kcal
Mrs. Joaquin's energy requirements are at least 2450 kcal/day or rounded to 2500 kcal/day.
The patient's signature on the informed consent form indicates that the patient understands the
Growth of the body and brain is dramatic over the first 2 years.
Likelihood of Developing Type 2 Diabetes Mellitus Based on BMI
A star link-type network where all of the modules are connected together using splice packs.
Severe periodontitis in a patient with uncontrolled diabetes.
Some Complications of Diabetes